Indications and Usage

SPRIX^® (ketorolac tromethamine) is indicated in adult patients for the short term (up to 5 days) management of moderate to
moderately severe pain that requires analgesia at the opioid level.

Limitations of Use

Sprix is not for use in pediatric patients less than 2 years of age.

REQUEST TELEREP

Important Safety Information Full Prescribing Information

This site is intended for US Healthcare professionals only.

REQUEST A SPRIX^® (KETOROLAC TROMETHAMINE) SALES REPRESENTATIVE

This is intended for US healthcare providers only. Please enter your contact information below.

*All required fields are marked with an asterisk.

First Name*

Last Name*

Practice Name*

Specialty

Email Address*

Address 1

Address 2 (optional)

City

State*

ZIP Code

Phone Number

Privacy

Assertio respects your right to have your personal information kept private. We may use this information to send you materials on our products and services that may be of interest to you. By submitting this registration, you understand that you are giving Assertio and its affiliates and business partners permission to use your personal information to provide you with information and offers related to support programs, treatment options, and services provided by Assertio. You understand that Assertio and its contractors will not sell or rent your personal information. For more information about how Assertio will use and protect your personal information, please read the Privacy Policy.

For more information about how Assertio will use and protect your personal information, please read the Privacy Policy.

Contact Assertio

100 South Saunders Road

Suite 300

Lake Forest, IL 60045

FOR SPRIX PRODUCT INFORMATION OR TO REPORT AN ADVERSE REACTION TO ASSERTIO:

PHONE: 866-458-6389

EMAIL: medinfo@assertiotx.com

To report adverse events to the FDA:

PHONE: 1-800-FDA-1088

www.fda.gov/medwatch

REQUEST A SPRIX® (KETOROLAC TROMETHAMINE) SALES REPRESENTATIVE